Global Transcatheter Aortic Valve Replacement (TAVR) Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region, By Country: Opportunities and Forecast (2017-2022) - By Region (North America, Europe, Asia Pacific, RoW); By Country (U.S., Canada, Germany, France, U.K., China, India, Japan, Brazil, South Africa)

 Published On: Apr, 2017 |    No of Pages: 140 |  Published By: Azoth Analytics | Format: PDF
Request Free Sample
Executive Summary

A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Transcatheter Aortic Valve Replacement Market, on the basis of Type of Approach (Transfemoral and Transapical); By Region (North America, Europe, APAC and ROW) and By Country (U.S., Canada, Germany, France, U.K., China, India, Japan, Brazil and South Africa).

Transcatheter aortic valve replacement (TAVR) has been a ground-breaking advancement in the field of interventional cardiology and cardiovascular surgery. Although, surgical aortic valve replacement is considered the standard treatment, yet 30% of patients are not considered candidates for traditional open heart surgery because of advanced age and presence of multiple comorbidities. Transcatheter aortic valve replacement offers this population a less invasive treatment option also with better outcomes. Over the recent years, the global TAVR industry has been growing rapidly mainly due to growing number of elderly population, rising awareness about minimally invasive devices, new device approvals and increasing health expenditure in developing countries.

According to Azoth Analytics research report, “Global Transcatheter Aortic Valve Replacement Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region (North America, Europe, Asia Pacific, Rest of the World), By Country (U.S., Canada, Germany, France, U.K., China, India, Japan, Brazil and South Africa): (2017-2022)” global market is projected to display a robust growth represented by a CAGR of 18.30% during 2017 – 2022, chiefly driven by large number of product approvals and launches, rising geriatric population, rapid adoption in U.S. and growing awareness about minimally invasive techniques.
Among the type of approach, transfemoral retrograde is the most common catheter-based approach and is performed in approximately 70% to 80% of the total TAVR cases, globally. Among the regions, Europe accounts for the largest regional share in the total TAVR market in 2016. However, Asia Pacific is predicted to advance at the highest rate, mainly driven by increase in healthcare expenditure coupled with growing penetration and awareness about technologically advanced heart valve therapies.

The report titled, “Global Transcatheter Aortic Valve Replacement Market: Analysis By Type of Approach (Transfemoral and Transapical), By Region (North America, Europe, Asia Pacific, Rest of the World), By Country (U.S., Canada, Germany, France, U.K., China, India, Japan, Brazil and South Africa): (2017-2022)” has covered and analysed the potential of Global Transcatheter Aortic Valve Replacement Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global transcatheter aortic valve market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Scope of the Report

Global Market (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Transcatheter Aortic Valve Replacement Market
• Transcatheter Aortic Valve Replacement Market- By Transfemoral Approach
• Transcatheter Aortic Valve Replacement Market- By Transapical Approach

Regional Markets – North America, Europe, APAC, RoW (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Transcatheter Aortic Valve Replacement Market
• Transcatheter Aortic Valve Replacement Market- By Transfemoral Approach
• Transcatheter Aortic Valve Replacement Market- By Transapical Approach

Country Analysis - US, Canada, UK, Germany, France, Japan, China, Singapore, India, Brazil, South Africa (Actual Period: 2012-2016, Forecast Period: 2017-2022)
• Transcatheter Aortic Valve Replacement Market

Other Report Highlights
• Market Dynamics – Trends, Drivers, Challenges
• Porter Five Forces Analysis
• SWOT Analysis
• Competitive Landscape
- Country Pricing and Volume Analysis
- Company Share Analysis
• Policy and Regulatory Landscape
• Company Analysis
- Edwards Lifesciences Corporation
- Medtronic Plc
- Boston Scientific Corporation
- St. Jude Medical Inc.
- JenaValve Technology Inc.
- Meril Life Sciences Pvt. Ltd.
 
Customization of the Report
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
Table of Contents

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation
3.1 Development and Commercialization of TAVR Therapies
3.2 Asia Pacific Region to witness the fastest growth in the market

4. Heart Valve Devices Outlook

5. Transcatheter Aortic Valve Replacement Outlook

6. Global Transcatheter Aortic Valve Replacement Market: Growth and Forecast
6.1 By Value (2012-2016)
6.2 By Value (2017-2022)

7. Global Transcatheter Aortic Valve Replacement Market-By Type of Approach
7.1 Global Transcatheter Aortic Valve Replacement Market-By Type of Approach (Replacement and Repair): Breakdown (%)
7.1.1 Global Transcatheter Aortic Valve Replacement Market Size, By Type of Approach, 2016 (%)
7.1.2 Global Transcatheter Aortic Valve Replacement Market Size, By Type of Approach, 2022 (%)
7.2 Global Transcatheter Aortic Valve Replacement Market- By Transfemoral Approach
7.2.1 By Value (2012-2016)
7.2.2 By Value (2017-2022)
7.3 Global Transcatheter Aortic Valve Replacement Market- By Transapical Approach
7.3.1 By Value (2012-2016)
7.3.2 By Value (2017-2022)

8. Global Transcatheter Aortic Valve Replacement Market: Regional Analysis

8.1 Global Transcatheter Aortic Valve Replacement Market, By Region: Breakdown (%)
8.1.1 Global Transcatheter Aortic Valve Replacement Market Size, By Region, 2016 (%)
8.1.2 Global Transcatheter Aortic Valve Replacement Market Size, By Region, 2022 (%)

8.2 North America Transcatheter Aortic Valve Replacement Market: An Analysis
8.2.1 By Value (2012-2016)
8.2.2 By Value (2017-2022)

8.3 North America Transcatheter Aortic Valve Replacement Market: By Type of Approach
8.3.1 North America Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value (2012-2016)
8.3.2 North America Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value (2017-2022)

8.4 North America Transcatheter Aortic Valve Replacement Market: Country Analysis (U.S. and Canada)
8.4.1 U.S. Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.4.2 Canada Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)

8.5 Europe Transcatheter Aortic Valve Replacement Market: An Analysis
8.5.1 By Value (2012-2016)
8.5.2 By Value (2017-2022)

8.6 Europe Transcatheter Aortic Valve Replacement Market: By Type of Approach
8.6.1 Europe Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value, 2012-2016
8.6.2 Europe Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value, 2017-2022

8.7 Europe Transcatheter Aortic Valve Replacement Market: Country Analysis (Germany, France, U.K. and Rest of Europe)
8.7.1 Germany Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.7.2 France Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.7.3 U.K. Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.7.4 Rest of Europe Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)

8.8 Asia Pacific Transcatheter Aortic Valve Replacement Market: An Analysis
8.8.1 By Value (2012-2016)
8.8.2 By Value (2017-2022)

8.9 APAC Transcatheter Aortic Valve Replacement Market: By Type of Approach
8.9.1 APAC Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value, 2012-2016
8.9.2 APAC Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value, 2017-2022

8.10 APAC Transcatheter Aortic Valve Replacement Market: Country Analysis (China, India, Japan & Rest of Asia Pacific)
8.10.1 China Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.10.2 India Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.10.3 Japan Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.10.4 Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)

8.11 Rest of the World Transcatheter Aortic Valve Replacement Market: An Analysis
8.11.1 By Value (2012-2016)
8.11.2 By Value (2017-2022)

8.12 RoW Transcatheter Aortic Valve Replacement Market: By Type of Approach
8.12.1 RoW Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value, 2012-2016
8.12.2 RoW Transcatheter Aortic Valve Replacement Market, By Type of Approach, By Value, 2017-2022

8.13 RoW Transcatheter Aortic Valve Replacement Market: Country Analysis (Brazil and South Africa)
8.13.1 Brazil Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)
8.13.2 South Africa Transcatheter Aortic Valve Replacement Market, By Value (2012-2022)

9. Market Dynamics
9.1 Global Transcatheter Aortic Valve Replacement Market Growth Drivers
9.2 Global Transcatheter Aortic Valve Replacement Market Restraints

10. Market Trends

11. Porter’s Five Forces Analysis – Transcatheter Aortic Valve Replacement Market

12. SWOT Analysis –Transcatheter Aortic Valve Replacement Market

13. Competitive Landscape
13.1 Global TAVR Market- Country Pricing and Volume Analysis
13.2 Global TAVR Market- Company Share Analysis

14. Policy and Regulatory Landscape

15. Company Profiling
15.1 Edwards Lifesciences Corporation
15.2 Medtronic Plc
15.3 Boston Scientific Corporation
15.4 St. Jude Medical Inc.
15.5 JenaValve Technology Inc.
15.6 Meril Life Sciences Pvt. Ltd.   

List of Figures

Figure 1: Heart Valve Problems and Disease Flowchart
Figure 2: Heart Valve Treatment Procedure Flowchart
Figure 3: Major Manufacturers of TAVR Systems and their Products
Figure 4: Global Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2016 (USD Million)
Figure 5: Global Transcatheter Aortic Valve Replacement Market Size, By Value, Forecast, 2017-2022(USD Million)
Figure 6: Global Population Ages 65 and Above, 2012-2016 (% of Total)
Figure 7: Global Diabetic Population, By Region, 2015 (Million)
Figure 8: Global Health Expenditure, 2011-2014 (% of GDP)
Figure 9: Global Transcatheter Aortic Valve Replacement Market Size, By Type of Approach, 2016 (%)
Figure 10: Global Transcatheter Aortic Valve Replacement Market Size, By Type of Approach, 2022 (%)
Figure 11: Global Transcatheter Aortic Valve Replacement Market, By Transfemoral Approach, By Value, 2012-2016 (USD Million)
Figure 12: Global Transcatheter Aortic Valve Replacement Market, By Transfemoral Approach, By Value, 2017-2022 (USD Million)
Figure 13: Global Transcatheter Aortic Valve Replacement Market, By Transapical Approach, By Value, 2012-2016 (USD Million)
Figure 14: Global Transcatheter Aortic Valve Replacement Market, By Transapical Approach, By Value, 2012-2016 (USD Million)
Figure 15: Global Transcatheter Aortic Valve Replacement Market Size, By Region, 2016 (%)
Figure 16: Global Transcatheter Aortic Valve Replacement Market Size, By Region, 2022 (%)
Figure 17: North America Transcatheter Aortic Valve Replacement Market, By Value, 2012-2016 (USD Million)
Figure 18: North America Transcatheter Aortic Valve Replacement Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 19: North America GDP, 2011-2015 (USD Trillion)
Figure 20: North America Healthcare Expenditure, 2011-2014 (% of GDP)
Figure 21: North America TAVR Market: By Type of Approach, By Value, 2012-2016 (USD Million)
Figure 22: North America TAVR Market: By Type of Approach, By Value, 2017-2022 (USD Million)
Figure 23: U.S. Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 24: U.S. Health Expenditure, 2012-2016 (% of GDP)
Figure 25: U.S. Population Ages 65 and above, 2014 and Forecast (Million)
Figure 26: U.S. Age Structure Breakdown, (%)
Figure 27: U.S Health Spending by Type of Service or Product, 2015 (%)
Figure 28: Canada Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 29: Europe Transcatheter Aortic Valve Replacement Market, By Value, 2012-2016 (USD Million)
Figure 30: Europe Transcatheter Aortic Valve Replacement Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 31: EU Health Expenditure Per Capita, 2011-2014 (USD)
Figure 32: Breakdown of Total Health Expenditure in Europe (%)
Figure 33: European Country Population Aged 65 and Above, 2012-2016 (% of Total)
Figure 34: Europe TAVR Market: By Type of Approach, By Value, 2012-2016 (USD Million)
Figure 35: Europe TAVR Market: By Type of Approach, By Value, 2017-2022 (USD Million)
Figure 36: Germany Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 37: Germany GDP Per Capita, PPP, 2012-2016 (USD)
Figure 38: Germany Age Structure Breakdown, (%)
Figure 39: France Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 40: U.K. Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 41: Rest of Europe Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 42: Asia Pacific Transcatheter Aortic Valve Replacement Market, By Value, 2012-2016 (USD Million)
Figure 43: Asia Pacific Transcatheter Aortic Valve Replacement Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 44: APAC Healthcare Expenditure Per Capita, 2011-2014 (% of GDP)
Figure 45: Asia Pacific Diabetes Prevalence, By Country, 2015 (% of Population Age 20 to 79)
Figure 46: Asia Pacific TAVR Market: By Type of Approach, By Value, 2012-2016 (USD Million)
Figure 47: Asia Pacific TAVR Market: By Type of Approach, By Value, 2017-2022 (USD Million)
Figure 48: China Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 49: China GDP Per Capita, 2012-2016 (USD)
Figure 50: China Population Aged 65 and Above, 2012-2016 (% of Total)
Figure 51: India Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 52: India Age Structure Breakdown, (%)
Figure 53: India Population Aged 65 and Above, 2012-2016 (% of Total)
Figure 54: Medical Tourist Arrival in India, By Country, 2015 (%)
Figure 55: Japan Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 56: Rest of Asia Pacific Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 57: Rest of the World Transcatheter Aortic Valve Replacement Market, By Value, 2012-2016 (USD Million)
Figure 58: Rest of the World Transcatheter Aortic Valve Replacement Market, By Value, Forecast, 2017-2022 (USD Million)
Figure 59: Middle East and North Africa Healthcare Expenditure, 2011-2014 (% of GDP)
Figure 60: Latin America Healthcare Expenditure, 2011-2014 (% of GDP)
Figure 61: RoW TAVR Market: By Type of Approach, By Value, 2012-2016 (USD Million)
Figure 62: RoW TAVR Market: By Type of Approach, By Value, 2017-2022 (USD Million)
Figure 63: Brazil Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 64: South Africa Transcatheter Aortic Valve Replacement Market Size, By Value, 2012-2022 (USD Million)
Figure 65: Global Transcatheter Aortic Valve Replacement Market Size, By Company Share, 2015 (%)
Figure 66: Classes of Medical Devices
Figure 67: Edwards Lifesciences Corporation Sales, 2012-2016 (USD Billion)
Figure 68: Edwards Lifesciences Corporation Sales, By Product Group, 2015 (%)
Figure 69: Edwards Lifesciences Corporation Sales, By Region, 2015 (%)
Figure 70: Edwards Lifesciences Corporation Product Group Sales Trend, 2013-2015 (USD Billion)
Figure 71: Medtronic Plc Sales, 2012-2016 (USD Billion)
Figure 72: Medtronic Plc Sales, By Business Group, 2015 (%)
Figure 73: Medtronic Plc Sales, By Region, 2015 (%)
Figure 74: Medtronic Plc Cardiac & Vascular Business Group Sales Trend, By Business Division 2014-2016 (USD Billion)
Figure 75: Medtronic Plc Cardiac & Vascular Business Group Sales, By Division 2016 (%)
Figure 76: Boston Scientific Corporation Sales, 2011-2015 (USD Billion)
Figure 77: Boston Scientific Corporation Sales, By Business Group, 2015 (%)
Figure 78: Boston Scientific Corporation Sales, By Region, 2015 (%)
Figure 79: Boston Scientific Corporation Cardiovascular Business Segment Sales Trend, By Division 2013-2015 (USD Billion)
Figure 80: Boston Scientific Corporation Cardiovascular Business Segment Sales, By Division 2015 (%)
Figure 81: St. Jude Medical Inc. Sales, 2011-2015 (USD Billion)
Figure 82: St. Jude Medical Inc. Sales, By Product Segment, 2015 (%)
Figure 83: St. Jude Medical Inc. Sales, By Region, 2015 (%)

List of Tables

Table A: Common Heart Valve Diseases, Symptoms and Causes
Table B: Comparison between transfemoral and transapical aortic valve implantation
Table C: Comparison of Transcatheter Heart Valves
Table D: Pricing Analysis of TAVR Device (Valve Cost) in Major Countries
Table E: Edwards Life Sciences TAVR Related Company Product Approval
Table F: Medtronic TAVR Related Company Product Approval
Table G: Medtronic Recent Merger, Acquisitions and Joint Venture Related to TAVR Systems
Table H: Boston Scientific Recent TAVR Related Company Product Approval

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.